NU-BLOG
Happenings and perspectives from Nusano and our collaborators
Nusano Announces Breakthrough HALEU Program Expected to Produce Up to 350 Metric Tons of Fuel Annually for Advanced Nuclear Reactors
Reservations available now, commercial production deliveries begin Q1 2027 Proprietary process with reduced environmental impacts Efficient domestic supply chain needed to support projected growth in energy demand from increased electrification and energy-intensive...
VIP Preview Tour Draws a Crowd
By Jessica Budin On June 9, 2025, Nusano welcomed more than 75 VIPs from throughout Utah for a preview of our new production facility. Attendees included government officials, local media outlets, university staff, trade associations, and customers. Nusano's CEO Chris...
Talk Radioisotopes: Sigal Kalmanson Cusnir, CEO and Co-Founder, Starget Pharma
In this episode of Talk Radioisotopes, host Scott Larrivee sits down with Sigal Kalmanson, CEO and Co-Founder of Starget Pharma, an early-stage company at the forefront of precision oncology. Starget is redefining the way radiopharmaceuticals are discovered and...
Talk Radioisotopes: Milton Lönnroth, Co-Founder and CEO, Atley Solutions
In this episode, Milton Lönnroth, Co-Founder and CEO, shares how Atley Solutions is changing the game for astatine-211, a promising isotope in cancer therapy. Atley supports radiopharmaceutical companies and researchers by enabling the scalable production and labeling...
Talk Radioisotopes: Dr. Luke Nordquist, Founder & CEO of XCancer
In this episode, host Scott Larrivee speaks with Dr. Luke Nordquist, a medical oncologist and Founder/CEO of XCancer, a globally recognized clinical research center. Dr. Nordquist shares the origin story of XCancer—born out of a desire to bring cutting-edge prostate...
Talk Radioisotopes: Matt Furlow, Associate Principal & Head of the ZS Radiopharmaceutical Center of Excellence
On this episode, hosts Scott Larrivee and Sarah Scouten are joined by Matt Furlow, Associate Principal & Head of the Radiopharmaceutical Center of Excellence at ZS, about the evolving role of radiopharmaceuticals in oncology. With a PhD in bioengineering...
Nusano CEO Chris Lowe on A Dose of Reality Podcast
Nusano CEO Chris Lowe appears on the A Dose of Reality podcast hosted by Charles Spence. The two discuss: 04:51 Proudest Moment of Chris in his Career and Leadership Philosophy 07:41 Nusano: Innovations in Medical Radioisotope Production 13:55 Building a Talented Team...
Talk Radioisotopes: Prof. Suzanne Lapi, University of Alabama at Birmingham
On this episode, hosts Scott Larrivee and Sarah Scouten sit down with Dr. Suzanne Lapi, Professor of Radiology and Chemistry and Cyclotron Facility Director at the University of Alabama at Birmingham. The conversation dives into Dr. Lapi’s multifaceted role in...
Talk Radioisotopes: Shamar Young, TeleDaaS
On this episode of the Talk Radioisotopes podcast, hosts Scott and Sarah are joined by Dr. Shamar Young, Chief Medical Officer at TeleDaaS and Division Chief of Interventional Radiology at the University of Arizona. The discussion explores Dr. Young’s journey into...
Nusano Featured in Salt Lake Business Journal
March 14, 2025 – Nusano's radioisotope production platform is profiled in a Salt Lake City Business Journal article: Chris Lowe, company CEO, said the origin of Nusano was “to address the underlying problems that have plagued national research labs and countries’...